Literature DB >> 18503910

Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs.

Sumeet Virmani1, Kathleen R Harris, Barbara Szolc-Kowalska, Tatjana Paunesku, Gayle E Woloschak, Fred T Lee, Robert J Lewandowski, Kent T Sato, Robert K Ryu, Riad Salem, Andrew C Larson, Reed A Omary.   

Abstract

PURPOSE: To compare two methods to (a) propagate VX2 cell strain in rabbit hind limbs and (b) inoculate liver parenchymal tumors in rabbits.
MATERIALS AND METHODS: One hundred forty-two New Zealand white rabbits were used for this study (60 with hind limb tumor [donors] and 82 with liver tumors [recipients]). In the donor group, nine rabbits received frozen VX2 cell suspension and 51 were injected with freshly prepared VX2 cell suspension. In the recipient group, 32 rabbits were injected with VX2 tumor cells and 50 were implanted with a small tumor fragment in the liver parenchyma. Success rates in terms of tumor growth were compared by using chi(2) or Fisher exact tests, with alpha = .05.
RESULTS: Hind limb and liver tumors were successfully grown in 48 of the 60 rabbits in the donor group (80%) and 57 of the 82 rabbits in the recipient group (70%). The success rate of growing hind limb tumors increased from 33% (three of nine rabbits) to 88% (45 of 51 rabbits) when fresh VX2 cells instead of frozen were injected percutaneously (P < .0011). Similarly, the success rate for VX2 liver tumors almost doubled from 47% (15 of 32 rabbits) to 84% (42 of 50 rabbits) when a tumor fragment instead of VX2 cell suspension was used (P < .00036). This also significantly reduced the frequency of metastasis (P < .005).
CONCLUSIONS: The authors recommend (a) the use of fresh VX2 cell suspension for percutaneous injection in the hind limbs of rabbits to maintain the VX2 cell strain and (b) the surgical implantation of freshly harvested VX2 tumor fragment into the liver parenchyma to establish liver tumors.

Entities:  

Mesh:

Year:  2008        PMID: 18503910      PMCID: PMC3006178          DOI: 10.1016/j.jvir.2008.02.019

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  21 in total

1.  Implantation of VX2 carcinoma into the liver of rabbits: a comparison of three direct-injection methods.

Authors:  Wan-Yu Lin; Jeonhor Chen; Yungchang Lin; Kunwang Han
Journal:  J Vet Med Sci       Date:  2002-07       Impact factor: 1.267

2.  Comparison between intravenous and intraarterial contrast injections for dynamic 3D MRI of liver tumors in the VX2 rabbit model.

Authors:  Andrew C Larson; Thomas K Rhee; Jie Deng; Dingxin Wang; Kent T Sato; Riad Salem; Tatjana Paunesku; Gayle Woloschak; Mary F Mulcahy; Debiao Li; Reed A Omary
Journal:  J Magn Reson Imaging       Date:  2006-07       Impact factor: 4.813

3.  18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.

Authors:  Tomohisa Okuma; Toshiyuki Matsuoka; Terue Okamura; Yasuhiro Wada; Akira Yamamoto; Yoshimasa Oyama; Koichi Koyama; Kenji Nakamura; Yasuyoshi Watanabe; Yuichi Inoue
Journal:  J Nucl Med       Date:  2006-08       Impact factor: 10.057

4.  Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase.

Authors:  Y H Ko; P L Pedersen; J F Geschwind
Journal:  Cancer Lett       Date:  2001-11-08       Impact factor: 8.679

5.  Combined hepatocyte-selective and blood-pool contrast agents for the CT detection of experimental liver tumors in rabbits.

Authors:  J P Weichert; F T Lee; S G Chosy; M A Longino; J E Kuhlman; D M Heisey; G E Leverson
Journal:  Radiology       Date:  2000-09       Impact factor: 11.105

6.  A simple cell-suspension method for transplantation of V2 carcinoma.

Authors:  D M Berkowitz; L Alexander; N K Hollenberg
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

7.  Induction of VX2 carcinoma in rabbit liver: comparison of two inoculation methods.

Authors:  J H Chen; Y C Lin; Y S Huang; T J Chen; W Y Lin; K W Han
Journal:  Lab Anim       Date:  2004-01       Impact factor: 2.471

8.  A new method for establishing an intrapulmonary tumor in the rabbit.

Authors:  Yuzo Shomura; Yukihito Saito; Kenichiro Minami; Hiroji Imamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-08

9.  Evaluation of experimental liver tumors using fluorine-18-2-fluoro-2-deoxy-D-glucose PET.

Authors:  N Oya; Y Nagata; T Ishigaki; M Abe; N Tamaki; Y Magata; J Konishi
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

10.  Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model.

Authors:  L H Ramirez; M Juliéron; M Bonnay; S Koscielny; Z Zhao; A Gouyette; J N Munck
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

View more
  31 in total

1.  Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors.

Authors:  Samdeep K Mouli; Patrick Tyler; Joseph L McDevitt; Aaron C Eifler; Yang Guo; Jodi Nicolai; Robert J Lewandowski; Weiguo Li; Daniel Procissi; Robert K Ryu; Y Andrew Wang; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  ACS Nano       Date:  2013-08-20       Impact factor: 15.881

2.  Development of a VX2 pancreatic cancer model in rabbits: a pilot study.

Authors:  Aaron C Eifler; Robert J Lewandowski; Sumeet Virmani; Johnathan C Chung; Dingxin Wang; Richard L Tang; Barbara Szolc-Kowalska; Gayle E Woloschak; Guang-Yu Yang; Robert K Ryu; Riad Salem; Andrew C Larson; Eric Cheon; Matthew Strouch; David J Bentrem; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2009-06-28       Impact factor: 3.464

3.  Four-dimensional transcatheter intraarterial perfusion MRI monitoring of radiofrequency ablation of rabbit VX2 liver tumors.

Authors:  Kent T Sato; Dingxin Wang; Robert J Lewandowski; Robert K Ryu; Rachel A Klein; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Magn Reson Imaging       Date:  2011-07-14       Impact factor: 4.813

4.  Comparison of two different laparotomy methods for modeling rabbit VX2 hepatocarcinoma.

Authors:  Zhu Chen; Zhen Kang; En-Hua Xiao; Min Tong; Yu-Dong Xiao; Hua-Bing Li
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

5.  Functional magnetic resonance imaging in an animal model of pancreatic cancer.

Authors:  Robert J Lewandowski; Aaron C Eifler; David J Bentrem; Johnathan C Chung; Dingxin Wang; Gayle E Woloschak; Guang-Yu Yang; Robert Ryu; Riad Salem; Andrew-C Larson; Reed-A Omary
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

6.  Confirmation of drug delivery after liver chemoembolization: direct tissue doxorubicin measurement by UHPLC-MS-MS.

Authors:  Sigrid Baumgarten; Ron C Gaba; Richard B van Breemen
Journal:  Biomed Chromatogr       Date:  2012-03-27       Impact factor: 1.902

7.  Modification of the method to establish a hepatic VX2 carcinoma model in rabbits.

Authors:  Huan Tong; Li-Geng Duan; Hong-Ying Zhou; Shi Feng
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

8.  Rabbit hepatic arterial anatomy variations: implications on experimental design.

Authors:  Alda L Tam; Marites P Melancon; Joe Ensor; Yang Liu; Katherine Dixon; Amanda McWatters; Sanjay Gupta
Journal:  Acta Radiol       Date:  2013-11-29       Impact factor: 1.990

9.  Intraprocedural diffusion-weighted PROPELLER MRI to guide percutaneous biopsy needle placement within rabbit VX2 liver tumors.

Authors:  Jie Deng; Sumeet Virmani; Guang-Yu Yang; Richard Tang; Gayle Woloschak; Reed A Omary; Andrew C Larson
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

10.  Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors.

Authors:  Sumeet Virmani; Thomas K Rhee; Robert K Ryu; Kent T Sato; Robert J Lewandowski; Mary F Mulcahy; Laura M Kulik; Barbara Szolc-Kowalska; Gayle E Woloschak; Guang-Yu Yang; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2008-10       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.